This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Ram Raghubir: Innovator in Antihyperglycemic and Antidyslipidemic Agents
Introduction
Ram Raghubir is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit antidiabetic properties. His work focuses on creating innovative solutions to combat hyperglycemia and dyslipidemia.
Latest Patents
One of Ram Raghubir's key patents is titled "Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents." This invention provides appropriately substituted chalcones, represented by a specific structural formula. The compounds are designed with various substituents, including H, OH, O-alkyl, O-phenyl, and O-substituted phenyl. The patent highlights the potential of these compounds to exhibit significant antidiabetic effects in various animal models, indicating their promise for further development and exploitation.
Career Highlights
Throughout his career, Ram Raghubir has demonstrated a strong commitment to research and innovation. His work has led to the successful development of a patent that addresses critical health issues related to diabetes and lipid metabolism. With a focus on scientific advancement, he continues to contribute to the field of medicinal chemistry.
Collaborations
Ram Raghubir has collaborated with notable colleagues, including Ram Pratap and Mavurapu Satyanarayana. These collaborations have fostered a productive research environment, enhancing the potential for innovative discoveries in their field.
Conclusion
In summary, Ram Raghubir is a distinguished inventor whose work in developing oxy substituted chalcones has the potential to significantly impact the treatment of diabetes and related conditions. His contributions to medicinal chemistry are noteworthy, and his ongoing research promises to yield further advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile